Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Chia Tai Tianqing Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Fosaprepitant dimeglumine
Fosaprepitant dimeglumine
2021-03-03
—
Fulvestrant
Fulvestrant
2020-02-07
2034
Breast neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fulvestrant
healthy volunteers/patients
,
pharmacokinetics
,
lymphoma
,
non-hodgkin lymphoma
,
acrocephalosyndactylia
,
endometrioid carcinoma
,
peritoneal neoplasms
,
hereditary breast and ovarian cancer syndrome
,
malignant mesothelioma
,
mesothelioma
,
pharmacological phenomena
,
sarcoma
,
adenocarcinoma
,
carcinosarcoma
,
digestive system neoplasms
,
urinary bladder neoplasms
,
neuroendocrine tumors
,
islet cell adenoma
,
urogenital neoplasms
,
female genital neoplasms
,
esophageal neoplasms
,
colonic neoplasms
,
spinocerebellar degenerations
,
fibrosis
,
inguinal hernia
,
hernia
,
gangrene
,
ovarian neoplasms
,
non-small-cell lung carcinoma
,
endometrial neoplasms
,
prostatic neoplasms
,
ovarian epithelial carcinoma
,
colorectal neoplasms
,
squamous cell carcinoma of head and neck
,
uterine cervical neoplasms
,
lung neoplasms
,
postmenopause
,
castration-resistant prostatic neoplasms
,
fallopian tube neoplasms
,
hereditary sensory and autonomic neuropathies
,
breast diseases
,
stomach neoplasms
,
small cell lung carcinoma
,
ductal carcinoma
,
liposarcoma
,
pancreatic neoplasms
,
carcinoma in situ
,
head and neck neoplasms
,
neoplasms by site
,
urologic neoplasms
,
uterine neoplasms
,
brain neoplasms
,
circulating neoplastic cells
,
intraductal carcinoma noninfiltrating
,
syndrome
,
melanoma
,
transitional cell carcinoma
,
squamous cell carcinoma
,
radiosurgery
,
biliary tract neoplasms
,
adenocarcinoma of lung
,
serous cystadenocarcinoma
,
leiomyosarcoma
,
adenosarcoma
,
sex cord-gonadal stromal tumors
,
endometrial stromal sarcoma
,
bone neoplasms
,
hypertension
,
pulmonary arterial hypertension
,
familial primary pulmonary hypertension
,
systemic lupus erythematosus
,
precocious puberty
,
polyostotic fibrous dysplasia
,
inborn genetic diseases
,
neutropenia
,
insulin resistance
,
hyperglycemia
,
hyperinsulinism
,
molecular targeted therapy
,
large b-cell lymphoma diffuse
,
salivary gland neoplasms
,
therapeutics
,
myxoid liposarcoma
,
esophageal squamous cell carcinoma
,
squamous cell neoplasms
,
skin neoplasms
,
carcinoma
,
recurrence
,
male breast neoplasms
,
invasive hydatidiform mole
,
disease progression
,
lobular carcinoma
,
ductal carcinoma breast
,
neoadjuvant therapy
,
progression-free survival
,
cholangiocarcinoma
,
unilateral breast neoplasms
,
breast neoplasms
,
neoplasms
,
triple negative breast neoplasms
,
neoplasm metastasis
,
multiple endocrine neoplasia type 1
,
eye abnormalities
Eribulin
lymphoma
,
skin neoplasms
,
cutaneous malignant melanoma
,
abdominal neoplasms
,
retroperitoneal neoplasms
,
renal insufficiency
,
ovarian neoplasms
,
lung neoplasms
,
ovarian epithelial carcinoma
,
prostatic neoplasms
,
liposarcoma
,
inflammatory breast neoplasms
,
melanoma
,
head and neck neoplasms
,
leiomyosarcoma
,
colorectal neoplasms
,
urethral neoplasms
,
ureteral neoplasms
,
renal cell carcinoma
,
fallopian tube neoplasms
,
ewing sarcoma
,
rhabdomyosarcoma
,
pancreatic neoplasms
,
pelvic neoplasms
,
colonic neoplasms
,
fatigue
,
circulating neoplastic cells
,
postmenopause
,
soft tissue neoplasms
,
malignant fibrous histiocytoma
,
residual neoplasm
,
solitary fibrous tumors
,
hemangiopericytoma
,
fibrous tissue neoplasms
,
hemangiosarcoma
,
epithelioid hemangioendothelioma
,
osteosarcoma
,
uterine cervical neoplasms
,
salivary gland neoplasms
,
castration-resistant prostatic neoplasms
,
uterine neoplasms
,
carcinosarcoma
,
mullerian mixed tumor
,
hepatocellular carcinoma
,
drug therapy
,
triple negative breast neoplasms
,
neoplasms
,
sarcoma
,
neoplasm metastasis
,
recurrence
,
carcinoma
,
non-small-cell lung carcinoma
,
brain neoplasms
,
urologic neoplasms
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
hereditary breast and ovarian cancer syndrome
,
adenocarcinoma
,
brca2 genes
,
invasive hydatidiform mole
,
meningeal neoplasms
,
meningeal carcinomatosis
,
mutation
,
breast neoplasms
,
male breast neoplasms
,
neurotoxicity syndromes
,
drug-related side effects and adverse reactions
,
peripheral nervous system diseases
,
alopecia areata
,
alopecia
,
treatment outcome
,
gastrointestinal neoplasms
Eribulin mesylate
ovarian neoplasms
,
ovarian epithelial carcinoma
,
liposarcoma
,
abdominal neoplasms
,
retroperitoneal neoplasms
,
lymphoma
,
renal insufficiency
,
neoplasms
,
recurrence
,
neoplasm metastasis
,
lung neoplasms
,
ewing sarcoma
,
rhabdomyosarcoma
,
brain neoplasms
,
prostatic neoplasms
,
soft tissue neoplasms
,
residual neoplasm
,
inflammatory breast neoplasms
,
solitary fibrous tumors
,
hemangiopericytoma
,
fibrous tissue neoplasms
,
hemangiosarcoma
,
epithelioid hemangioendothelioma
,
urinary bladder neoplasms
,
uterine neoplasms
,
carcinosarcoma
,
mullerian mixed tumor
,
triple negative breast neoplasms
,
sarcoma
,
non-small-cell lung carcinoma
,
breast neoplasms
,
male breast neoplasms
,
peripheral nervous system diseases
,
alopecia areata
,
alopecia
Sacituzumab
breast neoplasms
,
triple negative breast neoplasms
Mycophenolate sodium
autoimmune diseases
Benzimidazole
non-hodgkin lymphoma
,
lymphoma
,
b-cell lymphoma
Sintilimab
osteosarcoma
,
drug-related side effects and adverse reactions
,
adenocarcinoma of lung
,
meningeal carcinomatosis
,
gastrointestinal stromal tumors
,
cholangiocarcinoma
,
pancreatic neoplasms
,
t-cell lymphoma peripheral
,
t-cell lymphoma
,
biliary tract neoplasms
,
uterine cervical neoplasms
,
drug therapy
,
healthy volunteers/patients
,
large b-cell lymphoma diffuse
,
sarcoma
,
extranodal nk-t-cell lymphoma
,
chemoradiotherapy
,
colonic neoplasms
,
b-cell lymphoma
,
neuroendocrine carcinoma
,
molecular targeted therapy
,
thoracic neoplasms
,
ovarian neoplasms
,
neuroendocrine tumors
,
glioblastoma
,
brain neoplasms
,
neuroblastoma
,
multiple primary neoplasms
,
t-cell lymphoma cutaneous
,
microsatellite instability
,
mouth neoplasms
,
malignant mesothelioma
,
mesothelioma
,
radiosurgery
,
residual neoplasm
,
gastrointestinal neoplasms
,
digestive system neoplasms
,
ascites
,
clear cell adenocarcinoma
,
adenomyoepithelioma
,
mutation rate
,
microsatellite repeats
,
immunoblastic lymphadenopathy
,
disease
,
adoptive immunotherapy
,
respiratory tract diseases
,
lung diseases
,
precancerous conditions
,
aortic dissection
,
perioperative period
,
salivary gland neoplasms
,
unknown primary neoplasms
,
malignant fibrous histiocytoma
,
disorders of sex development
,
hemangiosarcoma
,
gastrectomy
,
kidney neoplasms
,
astrocytoma
,
oligodendroglioma
,
skin neoplasms
,
cutaneous malignant melanoma
,
appendiceal neoplasms
,
gallbladder neoplasms
,
lymphatic metastasis
,
head and neck neoplasms
,
airway obstruction
,
intensity-modulated radiotherapy
,
maintenance chemotherapy
,
follicular lymphoma
,
mantle-cell lymphoma
,
central nervous system neoplasms
,
vaginal neoplasms
,
vulvar neoplasms
,
spinocerebellar degenerations
,
hiv
,
acquired immunodeficiency syndrome
,
opportunistic infections
,
hepatocellular carcinoma
,
carcinoma
,
liver neoplasms
,
colorectal neoplasms
,
neoplasms
,
squamous cell carcinoma
,
esophageal squamous cell carcinoma
,
immunotherapy
,
neoplasm metastasis
,
rectal neoplasms
,
esophageal neoplasms
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
recurrence
,
squamous cell carcinoma of head and neck
,
small cell lung carcinoma
,
neoadjuvant therapy
,
radiotherapy
,
renal cell carcinoma
,
thrombosis
,
endometrial neoplasms
,
melanoma
,
squamous cell neoplasms
,
anus neoplasms
,
gastrointestinal diseases
,
esophageal diseases
,
hepatoblastoma
,
radiation pneumonitis
,
adjuvant chemotherapy
,
adjuvant radiotherapy
,
fertility
,
non-small-cell lung carcinoma
,
stomach neoplasms
,
lung neoplasms
,
adenocarcinoma
,
lymphoma
,
breast neoplasms
,
hodgkin disease
,
triple negative breast neoplasms
,
thyroid neoplasms
,
thyroid diseases
,
liver diseases
,
chronic hepatitis b
,
catheter ablation
,
female genital neoplasms
,
abdominal neoplasms
,
meningioma
,
venous thrombosis
,
hemophagocytic lymphohistiocytosis
,
analgesia
,
agnosia
,
delirium
,
gastrointestinal microbiome
,
acute kidney injury
,
tumor microenvironment
,
hepatitis b
,
hepatitis
,
chronic hepatitis
,
endometrioid carcinoma
,
leukemia
,
progression-free survival
Penpulimab
neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
gastrointestinal neoplasms
,
colorectal neoplasms
,
pancreatic neoplasms
,
nasopharyngeal neoplasms
,
urologic neoplasms
,
digestive system neoplasms
,
gastrointestinal stromal tumors
,
neuroendocrine tumors
,
thyroid neoplasms
,
small cell lung carcinoma
,
glioblastoma
,
stomach neoplasms
,
gastrointestinal diseases
,
digestive system diseases
,
nasopharyngeal carcinoma
,
rectal neoplasms
,
lymphoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
squamous cell neoplasms
,
esophageal squamous cell carcinoma
,
sarcoma
,
melanoma
,
pheochromocytoma
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
Cadonilimab
glioblastoma
,
skin neoplasms
,
neoplasms
,
esophageal squamous cell carcinoma
,
squamous cell carcinoma
,
neoplasm metastasis
,
melanoma
,
renal cell carcinoma
,
cholangiocarcinoma
,
pancreatic neoplasms
,
small cell lung carcinoma
,
esophageal neoplasms
,
endometrial neoplasms
,
immunotherapy
,
triple negative breast neoplasms
,
sarcoma
,
biliary tract neoplasms
,
urinary bladder neoplasms
,
squamous cell carcinoma of head and neck
,
breast neoplasms
,
squamous cell neoplasms
,
microsatellite instability
,
brain neoplasms
,
endometrioid carcinoma
,
thrombosis
,
radiosurgery
,
malignant mesothelioma
,
mesothelioma
,
ductal carcinoma
,
urologic neoplasms
,
kidney neoplasms
,
lymphoma
,
t-cell lymphoma
,
t-cell lymphoma peripheral
,
hypertension
,
portal hypertension
,
vulvar neoplasms
,
invasive hydatidiform mole
,
bile duct neoplasms
,
salivary gland neoplasms
,
transitional cell carcinoma
,
mutation rate
,
hysterectomy
,
recreational drug use
,
local neoplasm recurrence
,
pancreatic ductal carcinoma
,
meningeal carcinomatosis
,
carcinoma
,
hepatocellular carcinoma
,
uterine cervical neoplasms
,
non-small-cell lung carcinoma
,
colorectal neoplasms
,
liver neoplasms
,
adenocarcinoma
,
stomach neoplasms
,
lung neoplasms
,
recurrence
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
healthy volunteers/patients
,
ovarian neoplasms
,
neoadjuvant therapy
,
ovarian epithelial carcinoma
,
rectal neoplasms
,
drug therapy
,
radiotherapy
,
adjuvant chemotherapy
,
cryosurgery
,
small cell carcinoma
,
neuroendocrine carcinoma
Lanifibranor
pharmacokinetics
Gilvetmab
skin neoplasms
,
melanoma
,
neoplasm metastasis
Enoblituzumab
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
Efbemalenograstim alfa
neutropenia
,
non-small-cell lung carcinoma
,
lung neoplasms
,
febrile neutropenia
,
ovarian neoplasms
,
uterine cervical neoplasms
Aglatimagene besadenovec
anemia
,
breast neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
neoplasms
,
lung neoplasms
,
kidney neoplasms
,
prostatic hyperplasia
,
erectile dysfunction
,
hyperplasia
,
prostatic neoplasms
,
adenocarcinoma
,
urinary bladder neoplasms
,
lymphocele
Spartalizumab
ovarian neoplasms
,
lung neoplasms
,
neoplasm metastasis
,
kidney neoplasms
,
leukemia
,
myeloid leukemia acute
,
hematologic diseases
,
myeloid leukemia
,
myelomonocytic leukemia juvenile
,
preleukemia
,
bone marrow diseases
,
syndrome
,
colonic neoplasms
,
rectal neoplasms
,
essential thrombocythemia
,
polycythemia vera
,
primary myelofibrosis
,
thrombocytosis
,
polycythemia
,
glioblastoma
,
multiple myeloma
,
plasma cell neoplasms
,
alveolar soft part sarcoma
,
chordoma
,
neoplasms
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
colorectal neoplasms
,
carcinoma
,
breast neoplasms
,
renal cell carcinoma
,
pancreatic neoplasms
,
hepatocellular carcinoma
,
lymphoma
,
liver neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
adenocarcinoma
,
esophageal squamous cell carcinoma
,
squamous cell neoplasms
,
pancreatic ductal carcinoma
,
myelodysplastic syndromes
,
myelomonocytic leukemia chronic
,
ovarian epithelial carcinoma
,
gastrointestinal stromal tumors
,
sarcoma
,
anus neoplasms
,
small cell lung carcinoma
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
prostatic neoplasms
,
large b-cell lymphoma diffuse
,
neuroendocrine tumors
,
urologic neoplasms
,
thyroid neoplasms
,
esophageal neoplasms
,
uterine cervical neoplasms
,
cholangiocarcinoma
,
unknown primary neoplasms
,
adenocarcinoma of lung
,
clear cell adenocarcinoma
,
mesothelioma
,
carcinosarcoma
,
uveal neoplasms
,
adenomyoepithelioma
,
uveal melanoma
,
hematologic neoplasms
,
castration-resistant prostatic neoplasms
,
b-cell lymphoma
,
head and neck neoplasms
,
non-hodgkin lymphoma
,
neuroendocrine carcinoma
,
endometrial neoplasms
,
anaplastic thyroid carcinoma
,
melanoma
,
skin neoplasms
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use